SEWARD SQUARE GROUP for CAPITOL COUNSEL ON BEHALF OF RITE AID CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2014 | $20,000 | Replaced |
| 3rd Quarter - Amendment (No Activity) | Jul 21, 2020 | $30,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMIE FINCH | — |
| JAMES PERICOLA | — |
| RYAN THOMAS | — |
Medicare/Medicaid MMM
Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMIE FINCH | — |
| JAMES PERICOLA | — |
| RYAN THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.